Skip to main content
Top
Published in: Archives of Virology 3/2016

01-03-2016 | Brief Report

High-yield production of canine parvovirus virus-like particles in a baculovirus expression system

Authors: Hongli Jin, Xiaohong Xia, Bing Liu, Yu Fu, Xianping Chen, Huihui Wang, Zhenqiang Xia

Published in: Archives of Virology | Issue 3/2016

Login to get access

Abstract

An optimized VP2 gene from the current prevalent CPV strain (new CPV-2a) in China was expressed in a baculovirus expression system. It was found that the VP2 proteins assembled into virus-like particles (VLPs) with antigenic properties similar to those of natural CPV and with an especially high hemagglutination (HA) titer (1:220). Dogs intramuscularly or orally immunized with VLPs produced antibodies against CPV with >1:80 hemagglutination inhibition (HI) units for at least 3 months. The CPV VLPs could be considered for use as a vaccine against CPV or as a platform for research on chimeric VLP vaccines against other diseases.
Literature
1.
go back to reference Airenne KJ, Hu YC, Kost TA, Smith RH, Kotin RM, Ono C, Matsuura Y, Wang S, Yla-Herttuala S (2013) Baculovirus: an insect-derived vector for diverse gene transfer applications. Mol Ther 21:739–749PubMedCentralCrossRefPubMed Airenne KJ, Hu YC, Kost TA, Smith RH, Kotin RM, Ono C, Matsuura Y, Wang S, Yla-Herttuala S (2013) Baculovirus: an insect-derived vector for diverse gene transfer applications. Mol Ther 21:739–749PubMedCentralCrossRefPubMed
2.
go back to reference Buonavoglia C, Compagnucci M, Orfei Z (1983) Dog response to plaque variant of canine parvovirus. Zentralbl Veterinarmed B 30:526–531CrossRefPubMed Buonavoglia C, Compagnucci M, Orfei Z (1983) Dog response to plaque variant of canine parvovirus. Zentralbl Veterinarmed B 30:526–531CrossRefPubMed
3.
go back to reference Calderon MG, Mattion N, Bucafusco D, Fogel F, Remorini P, La Torre J (2009) Molecular characterization of canine parvovirus strains in Argentina: detection of the pathogenic variant CPV2c in vaccinated dogs. J Virol Methods 159:141–145CrossRefPubMed Calderon MG, Mattion N, Bucafusco D, Fogel F, Remorini P, La Torre J (2009) Molecular characterization of canine parvovirus strains in Argentina: detection of the pathogenic variant CPV2c in vaccinated dogs. J Virol Methods 159:141–145CrossRefPubMed
4.
go back to reference Casal JI (1999) Use of parvovirus-like particles for vaccination and induction of multiple immune responses. Biotechnol Appl Biochem 29(Pt 2):141–150PubMed Casal JI (1999) Use of parvovirus-like particles for vaccination and induction of multiple immune responses. Biotechnol Appl Biochem 29(Pt 2):141–150PubMed
5.
go back to reference Cavalli A, Bozzo G, Decaro N, Tinelli A, Aliberti A, Buonavoglia D (2001) Characterization of a canine parvovirus strain isolated from an adult dog. New Microbiol 24:239–242PubMed Cavalli A, Bozzo G, Decaro N, Tinelli A, Aliberti A, Buonavoglia D (2001) Characterization of a canine parvovirus strain isolated from an adult dog. New Microbiol 24:239–242PubMed
6.
go back to reference Cavalli A, Martella V, Desario C, Camero M, Bellacicco AL, De Palo P, Decaro N, Elia G, Buonavoglia C (2008) Evaluation of the antigenic relationships among canine parvovirus type 2 variants. Clin Vaccine Immunol 15:534–539PubMedCentralCrossRefPubMed Cavalli A, Martella V, Desario C, Camero M, Bellacicco AL, De Palo P, Decaro N, Elia G, Buonavoglia C (2008) Evaluation of the antigenic relationships among canine parvovirus type 2 variants. Clin Vaccine Immunol 15:534–539PubMedCentralCrossRefPubMed
7.
go back to reference Crisci E, Barcena J, Montoya M (2012) Virus-like particles: the new frontier of vaccines for animal viral infections. Vet Immunol Immunopathol 148:211–225CrossRefPubMed Crisci E, Barcena J, Montoya M (2012) Virus-like particles: the new frontier of vaccines for animal viral infections. Vet Immunol Immunopathol 148:211–225CrossRefPubMed
8.
go back to reference Decaro N, Desario C, Elia G, Martella V, Mari V, Lavazza A, Nardi M, Buonavoglia C (2008) Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c. New Microbiol 31:125–130PubMed Decaro N, Desario C, Elia G, Martella V, Mari V, Lavazza A, Nardi M, Buonavoglia C (2008) Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c. New Microbiol 31:125–130PubMed
9.
go back to reference Elia G, Desario C, Pezzoni G, Camero M, Brocchi E, Decaro N, Martella V, Buonavoglia C (2012) Recombinant ELISA using baculovirus-expressed VP2 for detection of antibodies against canine parvovirus. J Virol Methods 184:98–102CrossRefPubMed Elia G, Desario C, Pezzoni G, Camero M, Brocchi E, Decaro N, Martella V, Buonavoglia C (2012) Recombinant ELISA using baculovirus-expressed VP2 for detection of antibodies against canine parvovirus. J Virol Methods 184:98–102CrossRefPubMed
10.
go back to reference Feng H, Hu GQ, Wang HL, Liang M, Liang H, Guo H, Zhao P, Yang YJ, Zheng XX, Zhang ZF, Zhao YK, Gao YW, Yang ST, Xia XZ (2014) Canine parvovirus VP2 protein expressed in silkworm pupae self-assembles into virus-like particles with high immunogenicity. PLoS One 9:e79575PubMedCentralCrossRefPubMed Feng H, Hu GQ, Wang HL, Liang M, Liang H, Guo H, Zhao P, Yang YJ, Zheng XX, Zhang ZF, Zhao YK, Gao YW, Yang ST, Xia XZ (2014) Canine parvovirus VP2 protein expressed in silkworm pupae self-assembles into virus-like particles with high immunogenicity. PLoS One 9:e79575PubMedCentralCrossRefPubMed
11.
go back to reference Gil F, Brun A, Wigdorovitz A, Catala R, Martinez-Torrecuadrada JL, Casal I, Salinas J, Borca MV, Escribano JM (2001) High-yield expression of a viral peptide vaccine in transgenic plants. FEBS Lett 488:13–17CrossRefPubMed Gil F, Brun A, Wigdorovitz A, Catala R, Martinez-Torrecuadrada JL, Casal I, Salinas J, Borca MV, Escribano JM (2001) High-yield expression of a viral peptide vaccine in transgenic plants. FEBS Lett 488:13–17CrossRefPubMed
12.
go back to reference Gil F, Reytor E, Perez-Filgueira DM, Escribano JM (2007) Multimerization of peptide antigens for production of stable immunogens in transgenic plants. J Biotechnol 128:512–518CrossRefPubMed Gil F, Reytor E, Perez-Filgueira DM, Escribano JM (2007) Multimerization of peptide antigens for production of stable immunogens in transgenic plants. J Biotechnol 128:512–518CrossRefPubMed
13.
go back to reference Graf M, Bojak A, Deml L, Bieler K, Wolf H, Wagner R (2000) Concerted action of multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression. J Virol 74:10822–10826PubMedCentralCrossRefPubMed Graf M, Bojak A, Deml L, Bieler K, Wolf H, Wagner R (2000) Concerted action of multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression. J Virol 74:10822–10826PubMedCentralCrossRefPubMed
14.
go back to reference Gustafsson C, Govindarajan S, Minshull J (2004) Codon bias and heterologous protein expression. Trends Biotechnol 22:346–353CrossRefPubMed Gustafsson C, Govindarajan S, Minshull J (2004) Codon bias and heterologous protein expression. Trends Biotechnol 22:346–353CrossRefPubMed
15.
go back to reference Hu YC, Yao K, Wu TY (2008) Baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Rev Vaccines 7:363–371CrossRefPubMed Hu YC, Yao K, Wu TY (2008) Baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Rev Vaccines 7:363–371CrossRefPubMed
16.
go back to reference Ikemura T (1981) Correlation between the abundance of Escherichia coli transfer RNAs and the occurrence of the respective codons in its protein genes. J Mol Biol 146:1–21CrossRefPubMed Ikemura T (1981) Correlation between the abundance of Escherichia coli transfer RNAs and the occurrence of the respective codons in its protein genes. J Mol Biol 146:1–21CrossRefPubMed
17.
go back to reference Luckow VA (1993) Baculovirus systems for the expression of human gene products. Curr Opin Biotechnol 4:564–572CrossRefPubMed Luckow VA (1993) Baculovirus systems for the expression of human gene products. Curr Opin Biotechnol 4:564–572CrossRefPubMed
18.
19.
go back to reference Martella V, Cavalli A, Decaro N, Elia G, Desario C, Campolo M, Bozzo G, Tarsitano E, Buonavoglia C (2005) Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies. Clin Diagn Lab Immunol 12:1243–1245PubMedCentralPubMed Martella V, Cavalli A, Decaro N, Elia G, Desario C, Campolo M, Bozzo G, Tarsitano E, Buonavoglia C (2005) Immunogenicity of an intranasally administered modified live canine parvovirus type 2b vaccine in pups with maternally derived antibodies. Clin Diagn Lab Immunol 12:1243–1245PubMedCentralPubMed
20.
go back to reference Pollock RV, Carmichael LE (1982) Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination. J Am Vet Med Assoc 180:37–42PubMed Pollock RV, Carmichael LE (1982) Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination. J Am Vet Med Assoc 180:37–42PubMed
21.
go back to reference Pollock RV, Carmichael LE (1982) Dog response to inactivated canine parvovirus and feline panleukopenia virus vaccines. Cornell Vet 72:16–35PubMed Pollock RV, Carmichael LE (1982) Dog response to inactivated canine parvovirus and feline panleukopenia virus vaccines. Cornell Vet 72:16–35PubMed
22.
go back to reference Pratelli A, Cavalli A, Martella V, Tempesta M, Decaro N, Carmichael LE, Buonavoglia C (2001) Canine parvovirus (CPV) vaccination: comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine. Clin Diagn Lab Immunol 8:612–615PubMedCentralPubMed Pratelli A, Cavalli A, Martella V, Tempesta M, Decaro N, Carmichael LE, Buonavoglia C (2001) Canine parvovirus (CPV) vaccination: comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine. Clin Diagn Lab Immunol 8:612–615PubMedCentralPubMed
23.
go back to reference Saliki JT, Mizak B, Flore HP, Gettig RR, Burand JP, Carmichael LE, Wood HA, Parrish CR (1992) Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs. J Gen Virol 73(Pt 2):369–374CrossRefPubMed Saliki JT, Mizak B, Flore HP, Gettig RR, Burand JP, Carmichael LE, Wood HA, Parrish CR (1992) Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs. J Gen Virol 73(Pt 2):369–374CrossRefPubMed
24.
go back to reference Tokuoka M, Tanaka M, Ono K, Takagi S, Shintani T, Gomi K (2008) Codon optimization increases steady-state mRNA levels in Aspergillus oryzae heterologous gene expression. Appl Environ Microbiol 74:6538–6546PubMedCentralCrossRefPubMed Tokuoka M, Tanaka M, Ono K, Takagi S, Shintani T, Gomi K (2008) Codon optimization increases steady-state mRNA levels in Aspergillus oryzae heterologous gene expression. Appl Environ Microbiol 74:6538–6546PubMedCentralCrossRefPubMed
25.
26.
go back to reference Yi L, Tong M, Cheng Y, Song W, Cheng S (2014) Phylogenetic analysis of canine parvovirus VP2 gene in China. Transbound Emerg Dis. doi:10.1111/tbed.12268 Yi L, Tong M, Cheng Y, Song W, Cheng S (2014) Phylogenetic analysis of canine parvovirus VP2 gene in China. Transbound Emerg Dis. doi:10.​1111/​tbed.​12268
27.
go back to reference Yuan W, Parrish CR (2001) Canine parvovirus capsid assembly and differences in mammalian and insect cells. Virology 279:546–557CrossRefPubMed Yuan W, Parrish CR (2001) Canine parvovirus capsid assembly and differences in mammalian and insect cells. Virology 279:546–557CrossRefPubMed
28.
go back to reference Zhang R, Yang S, Zhang W, Zhang T, Xie Z, Feng H, Wang S, Xia X (2010) Phylogenetic analysis of the VP2 gene of canine parvoviruses circulating in China. Virus Genes 40:397–402CrossRefPubMed Zhang R, Yang S, Zhang W, Zhang T, Xie Z, Feng H, Wang S, Xia X (2010) Phylogenetic analysis of the VP2 gene of canine parvoviruses circulating in China. Virus Genes 40:397–402CrossRefPubMed
29.
go back to reference Zhi N, Wan Z, Liu X, Wong S, Kim DJ, Young NS, Kajigaya S (2010) Codon optimization of human parvovirus B19 capsid genes greatly increases their expression in nonpermissive cells. J Virol 84:13059–13062PubMedCentralCrossRefPubMed Zhi N, Wan Z, Liu X, Wong S, Kim DJ, Young NS, Kajigaya S (2010) Codon optimization of human parvovirus B19 capsid genes greatly increases their expression in nonpermissive cells. J Virol 84:13059–13062PubMedCentralCrossRefPubMed
Metadata
Title
High-yield production of canine parvovirus virus-like particles in a baculovirus expression system
Authors
Hongli Jin
Xiaohong Xia
Bing Liu
Yu Fu
Xianping Chen
Huihui Wang
Zhenqiang Xia
Publication date
01-03-2016
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 3/2016
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-015-2719-1

Other articles of this Issue 3/2016

Archives of Virology 3/2016 Go to the issue